Cryptosporidium Parvum: Polyamine Biosynthesis from Agmatine
N Yarlett,MP Martinez,G Zhu,JS Keithly,K Woods,SJ Upton
DOI: https://doi.org/10.1111/j.1550-7408.1996.tb05004.x
1996-01-01
Abstract:Cryptosporidium parvum belongs to a ubiquitous and diverse group of intracellular apicomplexans of both human and veterinary importance, which include the pathogens Plasmodium falciparwn. Toxoplasma gondii and Eimeria tenella. Ribosomal RNA data has shown that within the Apicomplexa, C. parvum forms an early branch point near the dinoflagellates and is more closely related to Plasmodium than to other coccidia [I-31. Our biochemical data, together with in vitro drug testing, show that C. parvum may in fact be even further removed from its nearest relatives. We show that, unlike most nonphotosynthetic eukaryotes, the starting point for polyamine biosynthesis by C. parvum is agmatine, which is formed from argkhe by arginine decarboxylase (ADC). We are also able to demonstrate the pathway of polyamine back-conversion via spermidine:spermine N1-acetyl transferase (SSAT). That this pathway is a rational target for drug development is indicated by our preliminary results which show that substrate analogues of ADC and SSAT are effective at reducing in vitro growth, and that in combination, inhibitors of both the forward and reverse pathways are synergistic growth inhibitors. MATERIALS AND METHODS. C. parvurn oocysts (Auburn 1) were obtained from milk-fed calves and provided by Dr. J. Vetterling. Parasitologic Services, Ft. Collins. CO. Oocysts purified on CsCl gradients, as previously described [4.5], were surface-sterilized using 10% (v/v) Cloroxm) and stored in K-dichromate. Excystation was performed using washed oocysts suspended in Hanks buffered salt solution (HBSS) containing 0.24% (w/v) txypsin and 0.75% (w/v) taurodeoxycholate for 2 h at 37O C. Sporozoites were centrifuged and resuspended to 5 x lO7/ml in HBSS containing 1 mdml each of w s i n inhibitor, aprotinin and N-p-tosyl-L-lysine chloromethyl ketone. In vitro drug screens were done using oocysts of strain KSU-1 adapted for growth in a human ileocaecal adenocarcinoma ( H a 8 ) cell line [5,6]. Parasite growth was determined by ELISA using a rat polyclonal antibody to C. parvum 23 kDa membrane protein, and then rabbit antirat serum conjugated to horse radish peroxidase [5.6]. ADC was assayed using 7 pCi [U-14C] arginine (327 mCi/mmol) in Tris-HC1 pH 6.7 containing 60 pM pyridoxal phosphate, 1 mM 2-mercaptoethanol and varying amounts (0.06 to 2.0 mM) of arginine. The 14C02 released in 60 min was trapped on hyamine-soaked filter paper and counted using a Beckman TriCarb scintillation counter [7]. SSAT was assayed in incubations containing 10 pM acetyl [ l -~~]coenzyme A (0.5 pCi), 0.1 mM bicine pH 7.0 and 3 mM spermine (or spermidme) for 5 to 60 min. The reaction was stopped by placing on ice and 0.2 M hydroxylamine was added. Samples were placed in a boiling water bath for 3 min. and the labeled product was collected on filter paper and counted using a Beckman TriCarb scintillation counter [8]. RESULTS AND DISCUSSION. In contrast to most other nonphotosynthetic eukaryotes. including other apicomplexans. polyamine biosynthesis by C. parvum was demonstrated to occur via ADC activity. Using Lieweaver-Burk analysis, the cryptosporidial enzyme had a V, of 325 44 pmoles/h/mg of protein and an apparent & of 200 pM for arginine. However, no decarboxylation of omithine could be detected over a pH range of 6.0 to 8.0 (limits of detection, 3 pmolesh), signifying that ADC is the sole route to polyamines. The decarboxylation of arginine was unaffected by 0.1 mM DL-adifluoromethylornithine (DFMO) indicating that ADC was measured, and that primary conversion of 14C-labeled arginine to omithine and subsequent 1%02 release can be excluded. As shown previously for ADCs from bacteria, plants and Trypanosomu cruzi [ 91 I], the enzyme from C. parvum was irreversibly inhibited by DLadifluoromethylargkhe (DFMA) with an estimated of 30 pM (using 10 to 100 pM DFMA in assays containing 100 p.M arginine). DFMA was also effective at reducing the in vitro growth of C. parvum (Iso 2.25 mM). The arginine analogue canavanine. has been demonstrated to disrupt plant growth by inhibition of ADC activity [12]. Canavanine was also effective at reducing in vitro growth of C. parvum. with an Iso of 1.5 mM. Consistent with our enzyme data, inhibitors of omithine decarboxylase (ODC) were ineffective as inhibitors of C. parvum growth (DLadifluoromethylornithine, monofluoromethylornithine, monoffuoromethyldehydroomithine). c o n f i i g the absence of ODC in this organism. Although effective, analogues of arginine were only growth-inhibitory when used at high dose (mM range) compared to beiig used as ADC activity inhibitors (pM range). These observations prompted us to look for alternative routes to polyamine biosynthesis and led us to find that C. parvum has SSAT activity, enabling backconversion of spamine to spermidine and putrescine. This enzyme has been shown to protect mammalian cells from polyamine depletion by inhibitors of the forward directed pathway [13,14]. Polyamine analogues, such as bis(ethy1)norspermine (BENSpm) have been shown to down-regulate SSAT in cancer cells resulting in reduced polyamine backconversion and thereby enabling enhanced efficiency of ODC inhibitors in these cell lines [15,16]. We are also able to demonstrate that BENSpm is weakly inhibitoq to in vitro growth of C. parvum (4 mM caused 6% growth inhibition), and that, in combination with 2 mM DFMA. it is synergistic, causing 60% growth inhibition. These results h i n t to polyamine biosynthesis as a potential target for chemotherapy of this parasite. [Supported by Pace University Scholarly Research Award (NY); Health Research Inc., NYSDOH grant 811-6617K (JSK); Pfizer Animal Health (SJU)].